Dublin, Sept. 18, 2017 -- The "DNA Sequencing - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them. Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2016 is described with estimates for 2021 and 2026. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 138 companies involved in sequencing and their 147 collaborations. The report text is supplementd by 42 tables, 22 figures and 500 selected references to the literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
15. References
For more information about this report visit https://www.researchandmarkets.com/research/8bwjss/dna_sequencing
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users 



